Evaluating the Efficacy of Artificial Intelligence Models in Predicting Intensive Care Unit Admission Needs

October 7, 2024 updated by: Engin Ihsan Turan, Kanuni Sultan Suleyman Training and Research Hospital
This study aims to evaluate the efficacy of two artificial intelligence (AI) models in predicting the need for ICU admissions. By comparing the AI models' predictions with actual clinical decisions, we aim to determine their accuracy and potential utility in clinical decision support.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Intensive care units (ICUs) are critical components of healthcare systems, providing life-saving care to patients with severe and life-threatening conditions. Timely and accurate prediction of ICU admission needs is essential for improving patient outcomes and optimizing hospital resource allocation. Delayed ICU admissions have been consistently associated with higher morbidity and mortality rates. With the advent of artificial intelligence (AI) in healthcare, there is an opportunity to enhance clinical decision-making by leveraging AI models to predict ICU needs accurately. AI models, such as ChatGPT and Gemini, can process vast amounts of complex data to identify patterns that might not be immediately evident to human clinicians, potentially improving the speed and accuracy of ICU admission decisions.

This is an observational retrospective study. Data were collected from electronic health records (EHRs) from a hospital retrospectively.

Data were extracted from EHRs and included:

Demographic data: Age, gender, and basic patient characteristics. Clinical parameters: Medication information, consultation details, ECG findings, imaging results, comorbid conditions (e.g., diabetes mellitus, hypertension, heart failure, COPD, cerebrovascular events), and laboratory values (e.g., hemoglobin, hematocrit, platelet count, PT, INR, procalcitonin, ALT, AST, bilirubin, sodium, potassium, chloride, glucose, creatinine, urea, albumin, thyroid function tests).

Prediction data: AI model predictions and actual ICU admission decisions.

Study Type

Observational

Enrollment (Actual)

8043

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34303
        • Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients over the age of 18 of both genders who are consulted for anesthesia regarding intensive care needs will be included in the study.

Description

Inclusion Criteria:

  • Patients over the age of 18
  • Patients consulted for anesthesia regarding intensive care needs
  • Patients with sufficient data in the hospital's electronic health record system

Exclusion Criteria:

  • Patients with insufficient data in the hospital records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Anesthesiologists Decision
Intensive Care Unit Follow up need is decided by anesthesiologists.

0: No need to follow up in Intensive Care Unit

1: Need to follow up in Intensive Care Unit

Artificial Intelligence Decision
Intensive Care Unit Follow up need is decided by Artificial Intelligence

0: No need to follow up in Intensive Care Unit

1: Need to follow up in Intensive Care Unit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intensive Care Unit Need
Time Frame: 1 day
The primary outcome measure of this study is the accuracy of the predictions made by the artificial intelligence (AI) models, ChatGPT and Gemini, regarding the need for ICU admissions. This will be evaluated by comparing the AI model predictions to the actual clinical decisions made regarding ICU admissions.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Engin ihsan Turan, Specialist, Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2024

Primary Completion (Actual)

October 1, 2024

Study Completion (Actual)

October 2, 2024

Study Registration Dates

First Submitted

July 3, 2024

First Submitted That Met QC Criteria

July 3, 2024

First Posted (Actual)

July 10, 2024

Study Record Updates

Last Update Posted (Actual)

October 8, 2024

Last Update Submitted That Met QC Criteria

October 7, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ICU-retro

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intensive Care Unit

Clinical Trials on Follow up Decision

Subscribe